Marine pharmacology in 2001-2: Antitumour and cytotoxic compounds

European Journal of Cancer

Volumn 40, Issue 18, 2004, Pages 2676-2704

  Mayer, Alejandro M S ^a   Gustafson, Kirk R ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b NCI Frederick   (United States)

Author keywords

Agents; Anticancer; Antineoplastic; Antitumour; Clinical; Cytotoxicity; Marine; Pharmacology; Preclinical; Review

Indexed keywords

AEROPLYSININ 1; AGOSTEROL A; ANTINEOPLASTIC AGENT; AURISTATIN PE; BRYOSTATIN 1; CALLYSTATIN A; CAULERPENYNE; CRYPTOPHYCIN 52; CRYPTOPHYCIN 55; CYCLOPRODIGIOSIN; CYTOTOXIC AGENT; DEHYDRODIDEMNIN B; DEHYDROTHYRSIFEROL; DIDEMNIN B; DISCODERMOLIDE; DOLASTATIN 11; ELEUTHEROBIN; ER 076349; FASCAPLYSIN; HALICONDRIN B DERIVATIVE; LOBATAMIDE A; LOBATAMIDE B; LOBATAMIDE C; LOBATAMIDE E; NATURAL PRODUCT; PEPTIDE; POLYKETIDE; STEROID; TERPENE; TRABECTEDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALGA; ANTINEOPLASTIC ACTIVITY; BACTERIUM; CLINICAL TRIAL; COLORECTAL CANCER; CYTOTOXICITY; DRUG MECHANISM; FATIGUE; FUNGUS; HODGKIN DISEASE; HUMAN; HYPONATREMIA; INVERTEBRATE; LEUKEMIA; LONG TERM CARE; MARINE ENVIRONMENT; MELANOMA; MYALGIA; NONHUMAN; PANCYTOPENIA; PHLEBITIS; PRIORITY JOURNAL; REVIEW;

EID: 9644278102     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.09.005     Document Type: Article

References (176)

1. A.M.S. Mayer Marine pharmacology in 1998: antitumor and cytotoxic compounds The Pharmacologist 41 1999 159 164
2. A.M.S. Mayer, and V.K.B. Lehmann Marine pharmacology in 1999: antitumor and cytotoxic compounds Anticancer Res. 21 2001 2489 2500
3. A.M.S. Mayer, and K.R. Gustafson Marine pharmacology in 2000: antitumor and cytotoxic compounds Int. J. Cancer 105 2003 291 299
4. J.W. Brown, C.T. Kesler, and J.T. Neary Effects of marine sponge extracts on mitogen-activated protein kinase (MAPK/ERK(1,2)) activity in SW-13 human adrenal carcinoma cells Toxicon 39 2001 1835 1839
5. S. Hiroishi, K. Sugie, and T. Yoshida Antitumor effects of Marginisporum crassissimum (Rhodophyceae), a marine red alga Cancer Lett. 167 2001 145 150
6. S. Aoki, Z.S. Chen, and K. Higasiyama Reversing effect of agosterol A, a spongean sterol acetate, on multidrug resistance in human carcinoma cells Jpn. J. Cancer Res. 92 2001 886 895
7. Z.S. Chen, S. Aoki, and M. Komatsu Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function Int. J. Cancer 93 2001 107 113
8. X.Q. Ren, T. Furukawa, and S. Aoki Glutathione-dependent binding of a photoaffinity analog of agosterol A to the C-terminal half of human multidrug resistance protein J. Biol. Chem. 276 2001 23197 23206
9. X.Q. Ren, T. Furukawa, and S. Aoki A positively charged amino acid proximal to the C-terminus of TM17 of MRP1 is indispensable for GSH-dependent binding of substrates and for transport of LTC4 Biochemistry 41 2002 14132 14140
10. S.G. Gomez, G. Faircloth, and L. Lopez-Lazaro In vitro hematotoxicity of Aplidine on human bone marrow and cord blood progenitor cells Toxicol. In Vitro 15 2001 347 350
11. B. Albella, G. Faircloth, and L. Lopez-Lazaro In vitro toxicity of ET-743 and aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors: comparison with the clinical results Eur. J. Cancer 38 2002 1395 1404
12. D'Incalci M. Editorial comment on "In vitro toxicity of ET-743 and Aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors: comparison with the clinical results" by Albella and colleagues. Eur J Cancer 2002, 38, 1297
13. E. Erba, L. Bassano, and G. Di Liberti Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine Br. J. Cancer 86 2002 1510 1517
14. S. Marchini, G. Chiorino, and G.T. Faircloth Changes in gene expression profile induced by the anticancer agent Aplidine in Molt-4 leukemic cell lines J. Biol. Regul. Homeost. Agents 16 2002 241 248
15. R.E. Curiel, C.S. Garcia, and L. Farooq Bryostatin-1 and IL-2 synergize to induce IFN-gamma expression in human peripheral blood T cells: implications for cancer immunotherapy J. Immunol. 167 2001 4828 4837
16. C.S. Chin, L.J. Graham, and G.G. Hamad Bryostatin/ionomycin-activated T cells mediate regression of established tumors J. Surg. Res. 98 2001 108 115
17. N.R. Wall, R.M. Mohammad, and A.M. Al Katib Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh Cell Growth Differ. 12 2001 641 647
18. J.A. Vrana, and S. Grant Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade Blood 97 2001 2105 2114
19. H. Lin, C. Chen, and X. Li Activation of the MEK/MAPK pathway is involved in bryostatin1-induced monocytic differenciation and up-regulation of X-linked inhibitor of apoptosis protein Exp. Cell Res. 272 2002 192 198
20. P.H. Roddie, Y. Horton, and M.L. Turner Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1 Leukemia 16 2002 84 93
21. Z. Wang, S. Wang, and Y. Dai Bryostatin 1 increases 1-beta-d- arabinofuranosylcytosine-induced cytochrome cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-x (L) J. Pharmacol. Exp. Ther. 301 2002 568 577
22. L.H. Cragg, M. Andreeff, and E. Feldman Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-d-arabinofuranosylcytosine in patients with refractory acute leukemia Clin. Cancer Res. 8 2002 2123 2133
23. J.L. Marshall, N. Bangalore, and D. El Ashry Phase I study of prolonged infusion bryostatin-1 in patients with advanced malignancies Cancer Biol. Ther. 1 2002 409 416
24. J.D. Roberts, M.R. Smith, and E.J. Feldman Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma Clin. Lymphoma 3 2002 184 188
25. B. Brockstein, B. Samuels, and R. Humerickhouse Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer Invest. New Drugs 19 2001 249 254
26. D.G. Pfister, J. McCaffrey, and A.J. Zahalsky A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck Invest. New Drugs 20 2002 123 127
27. A.Y. Bedikian, C. Plager, and J.R. Stewart Phase II evaluation of bryostatin-1 in metastatic melanoma Melanoma Res. 11 2001 183 188
28. R.G. Tozer, S. Burdette-Radoux, and K. Berlanger A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group study Invest. New Drugs 20 2002 407 412
29. F.H. Blackhall, M. Ranson, and J.A. Radford A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma Br. J. Cancer 84 2001 465 469
30. M.L. Varterasian, P.A. Pemberton, and K. Hulburd Phase II study of bryostatin 1 in patients with relapsed multiple myeloma Invest. New Drugs 19 2001 245 247
31. J.A. Zonder, A.F. Shields, and M. Zalupski A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer Clin. Cancer Res. 7 2001 38 42
32. K. Lu, J. Dempsey, and R.M. Schultz Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cells Cancer Chemother. Pharmacol. 47 2001 170 178
33. C. Sessa, K. Weigang-Kohler, and O. Pagani Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule Eur. J. Cancer 38 2002 2388 2396
34. M.K. Pec, A. Aguirre, and J.J. Fernandez Dehydrothyrsiferol does not modulate multidrug resistance-associated protein 1 resistance: a functional screening system for MRP1 substrates Int. J. Mol. Med. 10 2002 605 608
35. M.A. Baker, D.R. Grubb, and A. Lawen Didemnin B induces apoptosis in proliferating but not resting peripheral blood mononuclear cells Apoptosis 7 2002 407 412
36. D.R. Grubb, J.D. Ly, and F. Vaillant Mitochondrial cytochrome c release is caspase-dependent and does not involve mitochondrial permeability transition in didemnin B-induced apoptosis Oncogene 20 2001 4085 4094
37. L.E. Broker, C. Huisman, and C.G. Ferreira Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells Cancer Res. 62 2002 4081 4088
38. R.A. Isbrucker, S.P. Gunasekera, and R.E. Longley Structure-activity relationship studies of discodermolide and its semisynthetic acetylated analogs on microtubule function and cytotoxicity Cancer Chemother. Pharmacol. 48 2001 29 36
39. S.P. Gunasekera, G.K. Paul, and R.E. Longley Five new discodermolide analogues from the marine sponge Discodermia species J. Nat. Prod. 65 2002 1643 1648
40. S.P. Gunasekera, R.E. Longley, and R.A. Isbrucker Semisynthetic analogues of the microtubule-stabilizing agent discodermolide: preparation and biological activity J. Nat. Prod. 65 2002 1830 1837
41. R. Bai, P. Verdier-Pinard, and S. Gangwar Dolastatin 11, a marine depsipeptide, arrests cells at cytokinesis and induces hyperpolymerization of purified actin Mol. Pharmacol. 59 2001 462 469
42. T. Ogawa, Y. Mimura, and K. Isowa An antimicrotubule agent, TZT-1027, does not induce neuropathologic alterations which are detected after administration of vincristine or paclitaxel in animal models Toxicol. Lett. 121 2001 97 106
43. R.M. Mohammad, N.V. Adsay, and P.A. Philip Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model Anticancer Drugs 12 2001 735 740
44. K. Margolin, J. Longmate, and T.W. Synold Dolastatin-10 in metastatic melanoma: a phase II and pharmokinetic trial of the California Cancer Consortium Invest. New Drugs 19 2002 335 340
45. E.D. Saad, E.H. Kraut, and P.M. Hoff Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer Am. J. Clin. Oncol. 25 2002 451 453
46. G. Damia, S. Silvestri, and L. Carrassa Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways Int. J. Cancer 92 2001 583 588
47. E. Erba, D. Bergamaschi, and L. Bassano Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action Eur. J. Cancer 37 2001 97 105
48. Y. Takebayashi, P. Pourquier, and D.B. Zimonjic Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair Nat. Med. 7 2001 961 966
49. Y. Takebayashi, F. Goldwasser, and Y. Urasaki Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression Clin. Cancer Res. 7 2001 185 191
50. M. Zewail-Foote, V.S. Li, and H. Kohn The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent Chem. Biol. 8 2001 1033 1049
51. D. Friedman, Z. Hu, and E.A. Kolb Ecteinascidin-743 inhibits activated but not constitutive transcription Cancer Res. 62 2002 3377 3381
52. E. Marco, R. Garcia-Nieto, and J. Mendieta A 3. (ET743)-DNA complex that both resembles an RNA-DNA hybrid and mimicks zinc finger-induced DNA structural distortions J. Med. Chem. 45 2002 871 880
53. E.J. Martinez, E.J. Corey, and T. Owa Antitumor activity- and gene expression-based profiling of ecteinascidin Et 743 and phthalascidin Pt 650 Chem. Biol. 8 2001 1151 1160
54. A. Kanzaki, Y. Takebayashi, and X.Q. Ren Overcoming multidrug drug resistance in P-glycoprotein/MDR1-overexpressing cell lines by ecteinascidin 743 Mol. Cancer Ther. 1 2002 1327 1334
55. W.W. Li, N. Takahashi, and S. Jhanwar Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent Clin. Cancer Res. 7 2001 2908 2911
56. N. Takahashi, W.W. Li, and D. Banerjee Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells Clin. Cancer Res. 7 2001 3251 3257
57. K. Scotlandi, S. Perdichizzi, and M.C. Manara Effectiveness of Ecteinascidin-743 against drug-sensitive and - resistant bone tumor cells Clin. Cancer Res. 8 2002 3893 3903
58. S. Donald, R.D. Verschoyle, and R. Edwards Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female rat Cancer Res. 62 2002 4256 4262
59. J.M. Reid, M.J. Kuffel, and S.L. Ruben Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans Clin. Cancer Res. 8 2002 2952 2962
60. D.P. Ryan, J.G. Supko, and J.P. Eder Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies Clin. Cancer Res. 7 2001 231 242
61. A. Taamma, J.L. Misset, and M. Riofrio Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors J. Clin. Oncol. 19 2001 1256 1265
62. C. van Kesteren, C. Twelves, and A. Bowman Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study Anticancer Drugs 13 2002 381 393
63. M.A. Villalona-Calero, S.G. Eckhardt, and G. Weiss A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies Clin. Cancer Res. 8 2002 75 85
64. D.P. Ryan, T. Puchalski, and J.G. Supko A phase II and pharmacokinetic study of ecteinascidin 743 in patients with gastrointestinal stromal tumors Oncologist 7 2002 531 538
65. R. Britton, E.D. de Silva, and C.M. Bigg Synthetic transformations of eleutherobin reveal new features of its microtubule-stabilizing pharmacophore J. Am. Chem. Soc. 123 2001 8632 8633
66. A. Hormann, B. Chaudhuri, and H. Fretz DNA binding properties of the marine sponge pigment fascaplysin Bioorg. Med. Chem. 9 2001 917 921
67. M.J. Towle, K.A. Salvato, and J. Budrow In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B Cancer Res. 61 2001 1013 1021
68. D.P. Cioca, and K. Kitano Induction of apoptosis and CD10/neutral endopeptidase expression by jaspamide in HL-60 line cells Cell. Mol. Life Sci. 59 2002 1377 1387
69. K.A. Hood, B.T. Backstrom, and L.M. West The novel cytotoxic sponge metabolite peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C Anticancer Drug Des. 16 2001 155 166
70. K.A. Hood, L.M. West, and B. Rouwe Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule-stabilizing activity Cancer Res. 62 2002 3356 3360
71. S. Rodriguez-Nieto, M. Gonzalez-Iriarte, and R. Carmona Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge FASEB J. 16 2002 261 263
72. N. Murakami, M. Sugimoto, and M. Kobayashi Participation of the beta-hydroxyketone part for potent cytotoxicity of callystatin A, a spongean polyketide Bioorg. Med. Chem. 9 2001 57 67
73. P. Barbier, S. Guise, and P. Huitorel Caulerpenyne from Caulerpa taxifolia has an antiproliferative activity on tumor cell line SK-N-SH and modifies the microtubule network Life Sci. 70 2001 415 429
74. K. Kamata, S. Okamoto, and S. Oka Cycloprodigiosin hydrocloride suppresses tumor necrosis factor (TNF) alpha-induced transcriptional activation by NF-kappaB FEBS Lett. 507 2001 74 80
75. C. Yamamoto, H. Takemoto, and K. Kuno Cycloprodigiosin hydrochloride, a H+/Cl- symporter, induces apoptosis in human colon cancer cell lines in vitro Oncol. Rep. 8 2001 821 824
76. D. Yamamoto, K. Tanaka, and K. Nakai Synergistic effects induced by cycloprodigiosin hydrochloride and epirubicin on human breast cancer cells Breast Cancer Res. Treat. 72 2002 1 10
77. A.P. Brown, R.L. Morrissey, and G.T. Faircloth Preclinical toxicity studies of kahalalide F, a new anticancer agent: single and multiple dosing regimens in the rat Cancer Chemother. Pharmacol. 50 2002 333 340
78. R.W. Sparidans, E. Stokvis, and J.M. Jimeno Chemical and enzymatic stability of a cyclic depsipeptide, the novel, marine-derived, anti-cancer agent kahalalide F Anticancer Drugs 12 2001 575 582
79. B. Nuijen, M. Bouma, and C. Manada In vitro hemolysis and buffer capacity studies with the novel marine anticancer agent kahalalide F and its reconstitution vehicle cremophor EL/ethanol PDA J. Pharm. Sci. Technol. 55 2001 223 229
80. B. Nuijen, M. Bouma, and C. Manada Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devices Invest. New Drugs 19 2001 273 281
81. B. Nuijen, M. Bouma, and H. Talsma Development of a lyophilized parenteral pharmaceutical formulation of the investigational polypeptide marine anticancer agent kahalalide F Drug Dev. Ind. Pharm. 27 2001 767 780
82. B. Nuijen, M. Bouma, and P. Floriano Development of an HPLC method with UV detection for the pharmaceutical quality control of the novel marine anticancer agent kahalalide F J. Liq. Chromatogr. Relat. Technol. 24 2001 3141 3155
83. M.R. Boyd, C. Farina, and P. Belfiore Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases J. Pharmacol. Exp. Ther. 297 2001 114 120
84. C.D. Roskelley, D.E. Williams, and L.M. McHardy Inhibition of tumor cell invasion and angiogenesis by motuporamines Cancer Res. 61 2001 6788 6794
85. D.E. Williams, K.S. Craig, and B. Patrick Motuporamines, anti-invasion and anti-angiogenic alkaloids from the marine sponge Xestospongia exigua (Kirkpatrick): isolation, structure elucidation, analogue synthesis, and conformational analysis J. Org. Chem. 67 2002 245 258
86. K.A. Hood, L.M. West, and P.T. Northcote Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine Apoptosis 6 2001 207 219
87. H. Harada, U. Yamashita, and H. Kurihara Antitumor activity of palmitic acid found as a selective cytotoxic substance in a marine red alga Anticancer Res. 22 2002 2587 2590
88. D.K. Kim, M.Y. Lee, and H.S. Lee Polyacetylenes from a marine sponge Petrosia sp. inhibit DNA replication at the level of initiation Cancer Lett. 185 2002 95 101
89. S. Aoki, K. Higuchi, and N. Isozumi Differentiation in chronic myelogenous leukemia cell K562 by spongean sesterterpene Biochem. Biophys. Res. Commun. 282 2001 426 431
90. J.I. Williams, S. Weitman, and C.M. Gonzalez Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies Clin. Cancer Res. 7 2001 724 733
91. P. Schupp, K. Steube, and C. Meyer Anti-proliferative effects of new staurosporine derivatives isolated from a marine ascidian and its predatory flatworm Cancer Lett. 174 2001 165 172
92. G. Esposito, A. Aiello, and S. Carbonelli Mechanism of cytotoxicity of turbinamide in vitro Anticancer Res. 22 2002 2827 2831
93. M.C. Edler, A.M. Fernandez, and P. Lassota Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10 Biochem. Pharmacol. 63 2002 707 715
94. M. Iwashima, Y. Matsumoto, and Y. Takenaka New marine diterpenoids from the Okinawan soft coral Clavularia koellikeri J. Nat. Prod. 65 2002 1441 1446
95. N. Takada, M. Watanabe, and A. Yamada Isolation and structures of haterumadioxins A and B, cytotoxic endoperoxides from the Okinawan sponge Plakortis lita J. Nat. Prod. 64 2001 356 359
96. Y.J. Lim, H.S. Park, and K.S. Im Additional cytotoxic polyacetylenes from the marine sponge Petrosia species J. Nat. Prod. 64 2001 46 53
97. B.L. Marquez, K.S. Watts, and A. Yokochi Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly J. Nat. Prod. 65 2002 866 871
98. T. Yamada, C. Iwamoto, and N. Yamagaki Leptosins M-N-1, cytotoxic metabolites from a Leptosphaeria species separated from a marine alga. Structure determination and biological activities Tetrahedron 58 2002 479 487
99. N. Alam, B.H. Bae, and J.K. Hong Cytotoxic diacetylenes from the stony coral Montipora species J. Nat. Prod. 64 2001 1059 1063
100. C.Y. Duh, A.A. El Gamal, and C.Y. Chiang New cytotoxic xenia diterpenoids from the formosan soft coral Xenia umbellata J. Nat. Prod. 65 2002 1882 1885
101. D.R. Appleton, A.N. Pearce, and G. Lambert Isodiplamine, cystodytin K and lissoclinidine: novel bioactive alkaloids from the New Zealand ascidian Lissoclinum notti Tetrahedron 58 2002 9779 9783
102. C. Iwamoto, T. Yamada, and Y. Ito Cytotoxic cytochalasans from a Penicillium species separated from a marine alga Tetrahedron 57 2001 2997 3004
103. S. Kehraus, G.M. Konig, and A.D. Wright A new cytotoxic calyculinamide derivative, geometricin A, from the Australian sponge Luffariella geometrica J. Nat. Prod. 65 2002 1056 1058
104. T.N. Makarieva, E.A. Santalova, and I.A. Gorshkova A new cytotoxic fatty acid (5Z,9Z)-22-methyl-5,9-tetracosadienoic acid and the sterols from the far eastern sponge Geodinella robusta Lipids 37 2002 75 80
105. N. Borbone, S. De Marino, and M. Iorizzi Minor steroidal alkaloids from the marine sponge Corticium sp J. Nat. Prod. 65 2002 1206 1209
106. S.P. Chen, P.J. Sung, and C.Y. Duh Junceol A, a new sesquiterpenoid from the sea pen Virgularia juncea J. Nat. Prod. 64 2001 1241 1242
107. K.S. Craig, D.E. Williams, and I. Hollander Novel sesterterpenoid and norsesterterpenoid RCE-protease inhibitors isolated from the marine sponge Hippospongia sp Tetrahedron Lett. 43 2002 4801 4804
108. H. Gross, S. Kehraus, and G.M. Konig New and biologically active imidazole alkaloids from two sponges of the genus Leucetta J. Nat. Prod. 65 2002 1190 1193
109. S. Aoki, M. Okano, and K. Matsui Brianthein A, a novel briarane-type diterpene reversing multidrug resistance in human carcinoma cell line, from the gorgonian Briareum excavatum Tetrahedron 57 2001 8951 8957
110. Y.J. Lim, C.O. Lee, and J. Hong Cytotoxic polyacetylenic alcohols from the marine sponge Petrosia species J. Nat. Prod. 64 2001 1565 1567
111. J. Kimura, Y. Takada, and T. Inayoshi Kulokekahilide-1, a cytotoxic depsipeptide from the cephalaspidean mollusk Philinopsis speciosa J. Org. Chem. 67 2002 1760 1767
112. D. Laurent, G. Guella, and I. Mancini A new cytotoxic tetralone derivative from Humicola grisea, a filamentous fungus from wood in the southeastern lagoon of New Caledonia Tetrahedron 58 2002 9163 9167
113. H. Luesch, P.G. Williams, and W.Y. Yoshida Ulongamides A-F, new beta-amino acid-containing cyclodepsipeptides from Palauan collections of the marine cyanobacterium Lyngbya sp J. Nat. Prod. 65 2002 996 1000
114. H. Luesch, R. Pangilinan, and W.Y. Yoshida Pitipeptolides A and B, new cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula J. Nat. Prod. 64 2001 304 307
115. T. Miyamoto, K. Kodama, and Y. Aramaki Orostanal, a novel abeo-sterol inducing apoptosis in leukemia cell from a marine sponge, Stelletta hiwasaensis Tetrahedron Lett. 42 2001 6349 6351
116. M. Musman, I.I. Ohtani, and D. Nagaoka Hipposulfates A and B, new sesterterpene sulfates from an Okinawan sponge, Hippospongia cf. metachromia J. Nat. Prod. 64 2001 350 352
117. N.V. Petrichtcheva, C. Duque, and A. Duenas New nitrogenous eudesmane-type compounds isolated from the Caribbean sponge Axinyssa ambrosia J. Nat. Prod. 65 2002 851 855
118. L.M. Nogle, and W.H. Gerwick Somocystinamide A, a novel cytotoxic disulfide dimer from a Fijian marine cyanobacterial mixed assemblage Org. Lett. 4 2002 1095 1098
119. Y. Sakio, Y.J. Hirano, and M. Hayashi Dendocarbins A-N, new drimane sesquiterpenes from the nudibranch Dendrodoris carbunculosa J. Nat. Prod. 64 2001 726 731
120. G. Santafe, V. Paz, and J. Rodriguez Novel cytotoxic oxygenated C29 sterols from the Colombian marine sponge Polymastia tenax J. Nat. Prod. 65 2002 1161 1164
121. J.H. Sheu, G.H. Wang, and P.J. Sung Pachyclavulariolides G-L and secopachyclavulariaenone A, seven novel diterpenoids from the soft coral Pachyclavularia violacea Tetrahedron 57 2001 7639 7648
122. J.H. Sheu, and A.F. Ahmed Scabrolides A-D, four new norditerpenoids isolated from the soft coral Sinularia scabra J. Nat. Prod. 65 2002 1904 1908
123. D. Tasdemir, G.C. Mangalindan, and G.P. Concepcion Bioactive isomalabaricane triterpenes from the marine sponge Rhabdastrella globostellata J. Nat. Prod. 65 2002 210 214
124. Y.R. Torres, T.S. Bugni, and R.G. Berlinck Sebastianines A and B, novel biologically active pyridoacridine alkaloids from the Brazilian ascidian Cystodytes dellechiajei J. Org. Chem. 67 2002 5429 5432
125. N. Takada, R. Watanabe, and K. Suenaga Isolation and structures of hedaols A, B, and C, new bisnorditerpenes from a Japanese brown alga J. Nat. Prod. 64 2001 653 655
126. M. Tsuda, T. Endo, and Y. Mikami Luffariolides H and J, new sesterterpenes from a marine sponge Luffariella species J. Nat. Prod. 65 2002 1507 1508
127. G.H. Wang, J.H. Sheu, and C.Y. Duh Pachyclavulariaenones D-G, new diterpenoids from the soft coral Pachyclavularia violacea J. Nat. Prod. 65 2002 1475 1478
128. G.H. Wang, A.F. Ahmed, and J.H. Sheu Suberosols A-D, four new sesquiterpenes with beta-caryophyllene skeletons from a Taiwanese gorgonian coral Subergorgia suberosa J. Nat. Prod. 65 2002 887 891
129. A.M.S. Mayer Current marine pharmacology contributions to new drug development in the biopharmaceutical industry Pharmaceutical News 9 2002 479 482
130. S.H. Sennett, P.J. McCarthy, and A.E. Wright Natural products from marine invertebrates: the Harbor Branch Oceanographic Institution experience Pharmaceutical News 9 2002 483 488
131. W. Fenical, K.M. Sethna, and G.K. Lloyd Marine microorganisms as a developing resource for drug discovery Pharmaceutical News 9 2002 489 494
132. L.F. Garcia-Fernandez, F. Reyes, and J.M. Sanchez-Puelles The marine pharmacy:new antitumoral compounds from the sea Pharmaceutical News 9 2002 495 501
133. W. Bergmann, and R.J. Feeney Contributions to the study of marine products. XXXII. The nucleosides of sponges J. Org. Chem. 16 1951 981 987
134. J. Kobayashi, K. Shimbo, and M. Sato Amphidinolides H2-H5, G2, and G3, new cytotoxic 26- and 27-membered macrolides from dinoflagellate Amphidinium sp J. Org. Chem. 67 2002 6585 6592
135. H. Luesch, W.Y. Yoshida, and R.E. Moore Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula J. Am. Chem. Soc. 123 2001 5418 5423
136. H. Luesch, W.Y. Yoshida, and R.E. Moore New apratoxins of marine cyanobacterial origin from Guam and Palau Bioorg. Med. Chem. 10 2002 1973 1978
137. S. Tsukamoto, K. Tane, and T. Ohta Four new bioactive pyrrole-derived alkaloids from the marine sponge Axinella brevistyla J. Nat. Prod. 64 2001 1576 1578
138. M. Iwashima, I. Terada, and K. Iguchi New biologically active marine sesquiterpenoid and steroid from the okinawan sponge of the genus Axinyssa Chem. Pharm. Bull. (Tokyo) 50 2002 1286 1289
139. P.J. Sung, J.H. Su, and C.Y. Duh Briaexcavatolides K-N, new briarane diterpenes from the gorgonian Briareum excavatum J. Nat. Prod. 64 2001 318 323
140. S.L. Wu, P.J. Sung, and M.Y. Chiang New polyoxygenated briarane diterpenoids, briaexcavatolides O-R, from the gorgonian Briareum excavatum J. Nat. Prod. 64 2001 1415 1420
141. C.Y. Duh, A.A. El Gamal, and S.K. Wang Novel terpenoids from the formosan soft coral Cespitularia hypotentaculata J. Nat. Prod. 65 2002 1429 1433
142. M.A. Rashid, C.L. Cantrell, and K.R. Gustafson Chondropsin D, a new 37-membered-ring macrolide lactam from the marine sponge Chondropsis species J. Nat. Prod. 64 2001 1341 1344
143. C.Y. Duh, A.A. El Gamal, and C.J. Chu New cytotoxic constituents from the formosan soft corals Clavularia viridis and Clavularia violacea J. Nat. Prod. 65 2002 1535 1539
144. C.Y. Duh, M.C. Chia, and S.K. Wang Cytotoxic dolabellane diterpenes from the formosan soft coral Clavularia inflata J. Nat. Prod. 64 2001 1028 1031
145. S. Urban, J.W. Blunt, and M.H. Munro Coproverdine, a novel, cytotoxic marine alkaloid from a New Zealand ascidian J. Nat. Prod. 65 2002 1371 1373
146. K. Suwanborirux, K. Charupant, and S. Amnuoypol Ecteinascidins 770 and 786 from the Thai tunicate Ecteinascidia thurstoni J. Nat. Prod. 65 2002 935 937
147. Y.P. Shi, A.D. Rodriguez, and C.L. Barnes New terpenoid constituents from Eunicea pinta J. Nat. Prod. 65 2002 1232 1241
148. J.S. Sandler, P.L. Colin, and J.N. Hooper Cytotoxic beta-carbolines and cyclic peroxides from the Palauan sponge Plakortis nigra J. Nat. Prod. 65 2002 1258 1261
149. M.A. Rashid, K.R. Gustafson, and M.R. Boyd New cytotoxic N-methylated beta-carboline alkaloids from the marine ascidian Eudistoma gilboverde J. Nat. Prod. 64 2001 1454 1456
150. J.R. Rho, H.S. Lee, and C.J. Sim Gagunins, highly oxygenated diterpenoids from the sponge Phorbas sp Tetrahedron 58 2002 9585 9591
151. W.A. Gallimore, M. Kelly, and P.J. Scheuer Gelliusterols A-D, new acetylenic sterols from a sponge, Gellius species J. Nat. Prod. 64 2001 741 744
152. T. Yamada, K. Minoura, and A. Numata Halichoblelide, a potent cytotoxic macrolide from a Streptomyces species separated from a marine fish Tetrahedron Lett. 43 2002 1721 1724
153. M.J. Uddin, S. Kokubo, and K. Ueda Haterumaimides J and K, potent cytotoxic diterpene alkaloids from the ascidian Lissoclinum species Chem. Lett. 2002 1028 1029
154. J. Tanaka, A. Trianto, and M. Musman New polyoxygenated steroids exhibiting reversal of multidrug resistance from the gorgonian Isis hippuris Tetrahedron 58 2002 6259 6266
155. K.A. El Sayed, M. Kelly, and U.A. Kara New manzamine alkaloids with potent activity against infectious diseases J. Am. Chem. Soc. 123 2001 1804 1808
156. H. He, W.D. Ding, and V.S. Bernan Lomaiviticins A and B, potent antitumor antibiotics from Micromonospora lomaivitiensis J. Am. Chem. Soc. 123 2001 5362 5363
157. M.E.Y. Francisco, and K.L. Erickson Ma'iliohydrin, a cytotoxic chamigrene dibromohydrin from a Philippine Laurencia species J. Nat. Prod. 64 2001 790 791
158. F.D. Horgen, E.B. Kazmierski, and H.E. Westenburg Malevamide D: isolation and structure determination of an isodolastatin H analogue from the marine cyanobacterium Symploca hydnoides J. Nat. Prod. 65 2002 487 491
159. Y.C. Shen, C.Y. Chen, and Y.H. Kuo New sesquiterpene hydroquinones from a Taiwanese marine sponge, Hippospongia metachromia J. Nat. Prod. 64 2001 801 803
160. P. Phuwapraisirisan, S. Matsunaga, and R.W. van Soest Isolation of a new mycalolide from the marine sponge Mycale izuensis J. Nat. Prod. 65 2002 942 943
161. P.G. Williams, W.Y. Yoshida, and R.E. Moore Isolation and structure determination of obyanamide, a novel cytotoxic cyclic depsipeptide from the marine cyanobacterium Lyngbya confervoides J. Nat. Prod. 65 2002 29 31
162. I. Kuroda, M. Musman, and I.I. Ohtani Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, Pachastrissa sp J. Nat. Prod. 65 2002 1505 1506
163. H.S. Lee, Y. Seo, and J.R. Rho New steroidal alkaloids from an undescribed sponge of the genus Corticium J. Nat. Prod. 64 2001 1474 1476
164. Y.C. Shen, C.V. Prakash, and Y.H. Kuo Three new furan derivatives and a new fatty acid from a Taiwanese marine sponge Plakortis simplex J. Nat. Prod. 64 2001 324 327
165. A. Rueda, E. Zubia, and M.J. Ortega New acyclic sesquiterpenes and norsesquiterpenes from the Caribbean Gorgonian Plexaurella grisea J. Nat. Prod. 64 2001 401 405
166. M.A. Rashid, K.R. Gustafson, and R.C. Crouch Application of high-field NMR and cryogenic probe technologies in the structural elucidation of poecillastrin a, a new antitumor macrolide lactam from the sponge Poecillastra species Org. Lett. 4 2002 3293 3296
167. D.T. Youssef, R.K. Yamaki, and M. Kelly Salmahyrtisol A, a novel cytotoxic sesterterpene from the Red Sea sponge Hyrtios erecta J. Nat. Prod. 65 2002 2 6
168. N. Alam, W. Wang, and J. Hong Cytotoxic sphingosine4-sulfates from the sponge Spirastrella abata J. Nat. Prod. 65 2002 944 945
169. A. Grassia, I. Bruno, and C. Debitus Spongidepsin, a new cytotoxic macrolide from Spongia sp Tetrahedron 57 2001 6257 6260
170. K.M. Meragelman, T.C. McKee, and M.R. Boyd New cytotoxic isomalabaricane triterpenes from the sponge Jaspis species J. Nat. Prod. 64 2001 389 392
171. M. Musman, J. Tanaka, and T. Higa New sesquiterpene carbonimidic dichlorides and related compounds from the sponge Stylotella aurantium J. Nat. Prod. 64 2001 111 113
172. K. Warabi, Y. Nakao, and S. Matsunaga Dogger Bank Itch revisited: isolation of (2-hydroxyethyl) dimethylsulfoxonium chloride as a cytotoxic constituent from the marine sponge Theonella aff. mirabilis Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 128 2001 27 30
173. H. Luesch, W.Y. Yoshida, and R.E. Moore Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452 J. Nat. Prod. 65 2002 16 20
174. G.K. Paul, S.P. Gunasekera, and R.E. Longley Theopederins K and L. Highly potent cytotoxic metabolites from a marine sponge Discodermia species J. Nat. Prod. 65 2002 59 61
175. J. Malmstrom, C. Christophersen, and A.F. Barrero Bioactive metabolites from a marine-derived strain of the fungus Emericella variecolor J. Nat. Prod. 65 2002 364 367
176. C.Y. Duh, S.C. Chien, and P.Y. Song New cadinene sesquiterpenoids from the Formosan soft coral Xenia puerto-galerae J. Nat. Prod. 65 2002 1853 1856